U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07253246) titled 'ENX-205 SAD/PET Study in Healthy Adults' on Nov. 19.
Brief Summary: This is a two-part study designed to evaluate the safety, tolerability, pharmacokinetics (PK), and receptor occupancy (RO) of ENX-205 in healthy adult participants in a double-blind placebo-controlled, single ascending dose (SAD) study (Part 1) and an open-label, single-dose, positron emission tomography (PET) study (Part 2).
Study Start Date: May 23
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: ENX-205
oral solution
DRUG: Placebo
oral solution
Recruitment Status: RECRUITING
Sponsor: Engrail Therapeutics INC
Disclaimer: Cura...